JAMES BURKHART: Open Payments
NPI 1073350864 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$313 in 14 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $56 · 2025 $313
Food & beverage: $313
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 2 | $52 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Mallinckrodt Hospital Products Inc. | 1 | $35 |
| United Therapeutics Corporation | 1 | $31 |
| Aimmune Therapeutics, Inc. | 1 | $29 |
| GENZYME CORPORATION | 1 | $24 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| La Jolla Pharmaceutical Company | 1 | $17 |
| PFIZER INC. | 1 | $15 |
Products named: DUPIXENT, ACTHAR, Tyvaso, ZENPEP, WINREVAIR, OPSUMIT, AIRSUPRA, GIAPREZA.
Industry payments across TN — which companies pay providers there.
